Translate:

Twitter Facebook Linkedin

Search

Dr. Brian Koffman’s Blog

More Links

CLL Society

Patients and providers fighting CLL together

Smart Patients Get Smart Care™

Donate to CLL Society

Home
Basics
Beyond The Basics
Living Well With CLL
Clinical Trials
Conference Coverage
CAR-T
Support Groups/Education
News
About Us

CLL Society 2019 Website Survey

You are here:

Home
CLL Society 2019 Website Survey

We are grateful for your willingness to complete this short survey to help us better serve our community. Thank you.

Recent News

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
June 15, 2020
Living with CLL during the COVID19 Pandemic
June 1, 2020
Facebook Interview with Blood Cancers Uncensored
May 22, 2020

Conference Coverage

ASCO 2020 Top 12” #7: Tolerability and durable responses of the PI3Kδ inhibitor ME-401 administered on an intermittent schedule in relapsed/refractory (R/R) follicular lymphoma (FL) and other B-cell malignancies
July 10, 2020
ASCO 2020 Top 12” #8: Effect of adding ublituximab to ibrutinib on PFS, ORR, and MRD negativity in previously treated high-risk chronic lymphocytic leukemia: Final results of the GENUINE phase III study
July 10, 2020
ASCO 2020 Top 12” #9: Impact of premature venetoclax (Ven) discontinuation/interruption on outcomes in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Phase III MURANO study results
July 10, 2020
ASCO 2020 Top 12” #10: Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax
June 26, 2020
ASCO 2020 Top 12” #11: Clinical activity of cirmtuzumab, an anti-ROR1 antibody, in combination with ibrutinib: Interim results of a phase Ib/II study in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL)
June 26, 2020
ASCO 2020 Top 12” #12: The shift in therapies for the treatment of CLL patients in the US Veterans Health Administration (VHA) from 2013-2018
June 26, 2020

Chronic Lymphocytic Leukemia Toolbox

Abbreviations & Acronyms
Ask The Doctor
Ask The Pharmacist
Ask The Laboratory Scientist

Ask the Palliative Care/Hospice Doctor
Build-A-Team
CLL Doctors
CLL Glossary

CLL Links
Keeping Track Of
Lab Results
Normal Lab Values

Home
Basics
Beyond The Basics
Living Well With CLL
Clinical Trials
Conference Coverage
CAR-T
Support Groups/Education
News
About Us

Navigation

We’d like to thank our supporters:

AbbVie
AstraZeneca
Celgene
Genentech
Gilead
Pharmacyclics/Janssen
TG Therapeutics
Verastem

Copyright 2020 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy

This site uses cookies: Find out more.